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Abstract
Matrix metalloproteinases (MMPs) are zinc and calci-
um dependent enzymes capable of degrading almost 
all extracellular matrix and basement membrane com-
ponents. This group of proteolytic enzymes believed 
to be implicated in the breakdown of extracellular ma-
trix in normal physiological processes, as well as, plays 
an important role in many destructive pathological 
oral processes, such as periodontal tissue destruction, 
root caries, tumor invasion, and chronic periapical in-
flammation (CPL). The aim of this study was to analyze 
polymorphism in the gene MMP-1 and their associa-
tion and influence on clinical manifestation of chronic 
periapical lesions in order to provide new advances 
regarding the involvement of MMPs in various oral dis-
eases associated with the inflammatory process.
A total of 240 unrelated Macedonian subjects were in-
cluded in the present study. Polymorphism -1607 1G/2G 
in the gene MMP-1 detected with restriction enzymes 
AluI, XmnI and polymorphism -519 A/G in the gene 
MMP-1 detected with restriction enzyme KpnI was 
study in 120 patients with CPL and 120 controls without 
any signs of chronic or acute inflammatory process in 
the jaw. The amplification of the region of selected gene 
was made with polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP).
Our results showed that there was a differences in the 
allele and genotype frequencies of the MMP-1 poly-
morphism between patients with CPL and controls 
(p<0.05). Also this study suggests that MMP-1 poly-
morphism -1607 1G/2G detected with restriction en-
zymes AluI, XmnI was a risk for expression of CPL (OR 
= 18.38 < 4.06 < OR < 115.46; OR = 7.73 < 3.1 < OR < 
19.55) and MMP-1 polymorphism -519 A/G detected 
with restriction enzyme KpnI was a risk for expression 
of CPL (OR = 12.11 < 4.64 < OR < 32.30).
Detection of this genetic polymorphism is relevant for 
obtaining providential treatment of patients who are 
at high risk of chronic periapical inflammation.
Key words: Matrix metalloproteinases, Oral diseases, 
Polymerase chain reaction, Gene mutation.
1. Introduction
Matrix metalloproteinases (MMPs) are zinc and calci-
um dependent enzymes capable of degrading almost 
all extracellular matrix and basement membrane com-
ponents [1]. 
This group of proteolytic enzymes is believed to be 
implicated in the breakdown of extracellular matrix 
in normal physiological processes, such as: embryonic 
development, blastocyst implantation, organ morpho-
genesis, nerve growth, ovulation, cervical dilatation, 
postpartum uterine involution, endometrial cycling, 
hair follicle cycling, bone remodeling, wound healing, 
angiogenesis, apoptosis, etc. [2]. 
Matrixins play a critical role in pathological processes 
(e.g.: arthritis, cancer, cardiovascular disease, nephritis, 
neurological disease, breakdown of blood brain bar-
rier, periodontal disease, skin ulceration, gastric ulcer, 
corneal ulceration, liver fibrosis, emphysema, fibrotic 
lung disease, etc.) [3]. 
According to the important role of MMPs in inflam-
mation [4], it has been shown that genetic variation 
affecting the expression of MMPs influences the sus-
ceptibility and progression of various oral diseases [5]. 
Matrix metalloproteinases are strongly associated with 
levels of inflammation and play a major role in bone 
remodeling and bone resorption [6]. 
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Bone matrix is comprised mostly of mineralized fibrillar 
type I collagen. MMPs are capable of cleaving native, 
non-denatured collagens with long uninterrupted tri-
ple helices and can function as collagenases in vivo [7]. 
Expression of MMPs is low in normal cells, and these 
low levels allow for healthy connective tissue remod-
eling. In pathologic conditions, however, the level of 
MMPs expression increases considerably, resulting in 
aberrant connective tissue destruction. Expression of 
MMPs is regulated primarily at the transcriptional lev-
el where the promoter of the genes responds to dif-
ferent regulators [8]. Some functional polymorphisms 
have been described in the regulatory region of MMPs 
genes [5]. Because destructive enzymes of the MMPs 
family are involved in this process, allele polymor-
phisms of MMPs genes are interesting candidates for 
analyses of the influence, susceptibility and severity of 
chronic periapical lesions (CPLs). 
Subfamily of human collagenases has three members, 
from which MMP-1 (fibroblast type of collagenase, col-
lagenase-1) is one of our interest [9]. 
Gen of the MMP-1 is localized on chromosome 11q22 
and its expression was shown in various types of 
healthy cells (stromal fibroblasts, macrophage, endo-
thelial, and epithelial cells), as well as in different in-
flammatory and carcinoma cells [10]. 
Level of expression of MMP-1 can be under the influ-
ence of different single nucleotide polymorphism in 
promontory region. Insertion or deletion of the gua-
nine from the position -1607 can be identified in hu-
mans in promoter of the gen of MMP-1 developing two 
different alleles: one have single guanine (1G), and the 
other two guanine (2G) [11]. 
Patients who carried 2G allele have predisposition to 
develop several types of carcinoma or their rapid pro-
gression [12], to develop arthritis [5], arteriosclerosis, 
periodontitis [13], unsuccessful osteointegration of the 
implant [14], and coronary heart disease in patients 
with diabetes mellitus [15]. 
The aim of this study was to analyze polymorphism in 
the gene MMP-1 and their association and influence 
on clinical manifestation of chronic periapical lesions 
in order to provide new advances regarding the in-
volvement of MMPs in various oral diseases associated 
with the inflammatory process. 
2. Materials and Methods
2.1 Materials (patients’ samples)
Selection of the patients was made according to in-
ternal criteria, on the basis of sated clinical diagnosis, 
after detail analysis and clinical examination with anal-
ysis of X-ray changes. In this study patients who have 
antibiotic or immuno-suppressive therapy and those 
patients who have clinical signs of parodontopathia 
were excluded. Two groups were formed. First group 
was formed from 40 patients after clinically and radio-
graphic verified chronic periapical lesion. Second (con-
trol) group formed 120 patients without endodontic 
treated teeth and absents of chronic periapical process 
or acute odontogenic infection. 
In the aseptic condicions, from each patient with 
vene-punction, sample of vein blood (10mL) was taken 
in sterile epruvete (VaccutainerÒ) in which was antico-
agulant (EDTA.Na2). Ich sample was frozen at -80 0C as 
soon as possible and stored until the analysis. 
2.2 Methods
Standard isolation of genomic DNA from the nuclear 
cells was made with natrium chlorid extraction and af-
terwords precipitation with ethanol [16]. 
Table 1. Sequence of PCR primers with their restriction enzyme 
Gene Polymorphism Primer
PCR 
conditions
Length of PCR 
amplificat.
Restriction 
enzyme
Restriction
digestion
MMP-1 -1607 1G/2G
(F) 5’-TGA CTT TTA 
AAA CAT AGT CTA TGT 
TCA-3’
(R) 5’- TCT TGG ATT GAT 
TTG TTG AGA TAA GTC 
ATA GC-3’
35 cycles:
94 0C 30 s,
54 0C 30 s,
72 0C 30 s
269 bp AluI (241 + 28) bp
MMP-1 -1607 1G/2G
(F) 5’-TCG TGA GAA TGT 
CTT CCC ATT-3’
(R) 5’-TCT TGG ATT 
GAT TTG AGA TAA GTC 
ATA-3’
35 cycles: 
93 0C 30 s,
5 0C 30 s, 
72 0C 30 s, 
720C 5 min.
118 bp XmnI (29 + 89) bp
MMP-1 -519 A/G
(F) 5’-CAT GGT GCT ATC 
GCA ATA GGG T-3’
(R) 5’-TGC TAC AGG TTT 
CTC CAC ACA C-3’
30 cycles: 
94 0C 30 s, 
49 0C 30 s, 
72 0C 20 s, 
72 0C 4 min.
200 bp KpnI (176 + 24) bp
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Table 2. Representation of the polymorphism -1607 
1G/2G for the gene of MMP-1 detected with restristed 
enzyme AluI in patients from examined groups
Polymorphism
of MMP-1 
detected with 
restricted 
enzyme AluI
No
and 
%
Examined groups
TotalChronic 
periapical
lesions
Control 
group
-/- 
(homozygotes 
for absence)
No 2 59 61
% 5% 49.2% 43.6%
+/+ 
(homozygotes 
for presence)
No 19 10 29
% 47.5% 8.3% 20.7%
-/+ 
(heterozygotes 
for presence)
No 19 51 70
% 47.5% 42.5% 50%
Samples of DNA izolates were aliqvated in few epru-
vetes, from wich, one was keeped from +4 0C till +8 
0C, and that one was used for analysis. The other EDTA 
tubes were kept as a reserve in the bank of samples at 
temperature from -18 till -20 0C. Amplification of the 
regions of elected genes was made with polymerase 
chain reaction (PCR) and performed in PCR machine 
(Perkin-Elmer Gene Amp System 2400).
Presence or absence of some normal or mutated se-
quence in PCR product followed by restriction diges-
tion results with different size of fragments (Table 1).
Successful amplification was verified with presence 
of electrophoresis marker (PCR Marker, Bio-Rad) with 
agrarelectrophoreze (Bio-Rad, USA). Production of di-
gestion were vizualized with fluoroscence painting of 
the gel with etidium bromid. 
3. Results and Discussion
3.1 Results
Representation of the polymorphism -1607 1G/2G of 
the gene of MMP-1 detected with restricted enzyme 
AluI in the patients from examined groups is shown in 
Table 2.
Statistical analysis confirm that there is a statistical sig-
nificance between gene poymorphism of MMP-1 de-
tected with restriction enzyme AluI and CPL (Pearson 
Chi-square: 40.9120, df = 2, p = 0.000000). Polymor-
phism -1607 1G/2G for the gene of MMP-1 detected 
with restictive enzyme AluI was risk factor for expres-
sion of chronic periapical lesion (OR = 18.38 < 4.06 
< OR < 115.46). 
Representation of the polymorphism -1607 1G/2G of 
the gene of MMP-1 detected with restricted enzyme 
XmnI in the patients from examined groups is shown 
in Table 3. 
Statistical analysis confirm that there is a statistical sig-
nificance between gene poymorphism of MMP-1 de-
tected with restriction enzyme XmnI and CPL (Pearson 
Chi-square: 57.5222, df = 2, p = 0.000000). Polymor-
phism -1607 1G/2G for the gene of MMP-1 detected 
with restictive enzyme AluI was risk factor for expres-
sion of chronic periapical lesion (OR = 7.73 < 3.1 < OR 
< 19.55).
Representation of the polymorphism -519 A/G of the 
gene of MMP-1 detected with restricted enzyme KpnI 
in the patients from examined groups is shown in 
 Table 4. 
Statistical analysis confirm that there is a statistical 
significance between gene poymorphism of MMP-1 
detected with restriction enzyme KpnI and CPL (Pear-
son Chi-square: 45.8285, df = 2, p = 0.000000). Poly-
morphism -519 A/G for the gene of MMP-1 detected 
Table 3. Representation of the polymorphism -1607 
1G/2G for the gene of MMP-1 detected with restristed 
enzyme XmnI in patients from examined groups
Polymorphism
of MMP-1 
detected with 
restricted 
enzyme XmnI
No
and
%
Examined groups
TotalChronic 
periapical
lesions
Control 
group
-/- 
(homozygotes 
for absence)
No 9 83 92
% 22.5% 69.2% 68.3%
+/+ 
(homozygotes 
for presence)
No 24 7 31
% 60% 5.8% 22.1%
-/+ 
(heterozygotes 
for presence)
No 7 30 37
% 17.5% 25% 26.4%
Table 4. Representation of the polymorphism -519 A/G 
for the gene of MMP-1 detected with restristed enzyme 
KpnI in patients from examined groups 
Polymorphism 
of MMP-1 
detected with 
restricted 
enzyme KpnI
Number
Examined groups
TotalChronic 
periapical
lesions
Control 
group
-/- 
(homozygotes 
for absence)
N 18 109 127
% 45% 90.8% 90.7%
+/+ 
(homozygotes 
for presence)
N 9 / 9
% 22.5% / 6.4%
-/+ 
(heterozygotes 
for presence)
N 13 11 24
% 32.5% 9.2% 17.1%
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with restictive enzyme KpnI was risk factor for expres-
sion of chronic periapical lesion (OR = 12,11 < 4.64 
< OR < 32.30). 
Detected frequence of 2G allel in polymorphs -1607 
1G/2G of the gene for MMP-1 detected with restricted 
enzyme XmnI was significant higher in patients with 
CPL than those from the control group (f(2G) = 0.18). 
With that we can confirm protective role of 1G allele for 
developing an inflammatory process. Frequency of the 
genotypes was f(1G/1G) = 0,2; f(1G/2G) = 0.2; f(2G/2G) 
= 0,6 and p < 0.05 (p = 0,0002) witch shows that there 
is an equilibrium (Table 5). 
Frequency of the genotypes was f(1G/1G) = 0,7; 
f(1G/2G) = 0.2; f(2G/2G) = 0,1 and p > 0.05 (p = 0,0002) 
witch shows that there is no equilibrium (Table 6). 
Detected frequence of 2G allel in polymorphs -1607 
1G/2G of the gene for MMP-1 detected with restricted 
enzyme AluI was significant higher in patients with CPL 
than those from the control group (f(2G) = 0.30). Fre-
quency of the genotypes was f(1G/1G) = 0,0; f(1G/2G) 
= 0.5 f(2G/2G) = 0,5 and p > 0.05 (p = 0,3133) witch 
shows that there is no equilibrium (Table 7). 
Frequency of the genotypes was f(1G/1G) = 0,5; 
f(1G/2G) = 0,4; f(2G/2G) = 0,1 and p > 0.05 (p = 0,8259) 
witch shows that there is no equilibrium (Table 8). 
Detected frequence of 2G allel in polymorphs -519 
A/G of the gene for MMP-1 detected with restricted 
enzyme KpnI was significant higher in patients with 
CPL than those from the control group (f(G) = 0.05). 
With that we can confirm protective role of A allele in 
this polymorphism for developing an inflammatory 
process. Frequency of the genotypes was f(A/A) = 0,5; 
f(A/G) = 0; f(G/G) = 0,2 and p < 0.05 (p = 0,0461) witch 
shows that there is an equilibrium (Table 9). 
Frequency of the genotypes was f(A/A) = 0,9; f(A/G) = 
0,1; f(G/G) = 0,0 and p > 0.05 (p = 0,5988) witch shows 
that there is no equilibrium (Table 10). 
3.2 Discussion
MMPs play an important role during periapical pathol-
ogy development [17], and it has been suggested that 
the modality of root canal treatment could interfere 
with MMPs expression [18]. 
Due to their various roles in bone remodeling, immune 
responses, caries, and dental development, it is hypoth-
esize that variation in MMPs and TIMP genes may alter 
the level of bone destruction and remodeling and con-
tribute to the formation of more extensive periapical 
lesions in teeth affected by deep carious lesions. [19, 20]. 
Results in our study indicate that individual genet-
ic predisposition have influence on periapical lesion 
formation. We can confirm that polymorphism of the 
Table 5. Frequency of the allels in the polymorphism 
-1607 1G/2G for the gene of MMP-1 detected with 
 restristed enzyme XmnI in patients with CPL 
Genotype 1G/ 1G
1G/ 
2G
2G/ 
2G Total
Frequency of 
the alleles
Number n 9 7 24 40 80
Allel 1G 18 7 0 25 0,31
Allel 2G 0 7 48 55 0,69
Table 6. Frequency of the allels in the polymorphism 
-1607 1G/2G for the gene of MMP-1 detected with 
 restristed enzyme XmnI in patients from controle group
Genotype
1G/ 
1G
1G/ 
2G
2G/ 
2G
Total
Frequency of 
the alleles
Number n 83 30 7 120 240
Allel 1G 166 30 0 196 0,82
Allel 2G 0 30 14 44 0,18
Table 7. Frequency of the allels in the polymorphism 
-1607 1G/2G for the gene of MMP-1 detected with 
 restristed enzyme AluI in patients with CPL 
Genotype
1G/ 
1G
1G/ 
2G
2G/ 
2G
Total
Frequency of 
the alleles
Number n 2 19 19 40 80
Allel 1G 4 19 0 23 0,29
Allel 2G 0 19 38 57 0,71
Table 8. Frequency of the allels in the polymorphism 
-1607 1G/2G for the gene of MMP-1 detected with 
 restristed enzyme AluI in patients from controle group
Genotype
1G/ 
1G
1G/ 
2G
2G/ 
2G
Total
Frequency of 
the alleles
Number n 59 51 10 120 240
Allel 1G 118 51 0 169 0,70
Allel 2G 0 51 20 71 0,30
Table 9. Frequency of the allels in the polymorphism 
-519 A/G for the gene of MMP-1 detected with restristed 
 enzyme KpnI in patients with CPL
Genotype A/A A/G G/G Total
Frequency of 
the alleles
Number n 10 22 8 40 80
Allel A 20 22 0 42 0,52
Allel G 0 2 16 38 0,48
Table 10. Frequency of the allels in the polymorphism 
-519 A/G for the gene of MMP-1 detected with restristed 
enzyme KpnI in patients from controle group
Genotype A/A A/G G/G Total
Frequency of 
the alleles
Number n 59 51 10 120 240
Allel A 118 51 0 169 0,70
Allel G 0 51 20 71 0,30
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gene for MMP-1 contributes for increasing individual 
frequency of apical tissue destruction as a reaction to 
deep caries lesion. 
Our results are in correlation with findings of Rutter et 
al., [11] in which is show that this polymorphism can 
have functional consequences because can affect the 
function of MMP-1, as well as, is polymorphism who is 
candidate with strong biological significance for devel-
oping inflammatory process. 
Also our result are in correlation with finding of Cao et 
al., [21] in which genetic variations in promontory re-
gion of the gene of MMP-1 have influence on the tran-
scription level and as a results of this, the gen of MMP-1 
have crucial role in degradation of connected tissue in 
periodontis. 
Beside this, Itagaki et al., [9], have not detected differ-
ences between allele of the gene of MMP-1 and geno-
typic distribution in healthy Japanese and those with 
chronic periodontitis. 
Findings about the detected frequence of G allel in 
polymorphs -519 A/G of the gene for MMP-1in our 
study are in relationship with findings of Oh et al.[22], 
where is observed similar distribution of the geno-
types and frequencies of the alleles. 
Polymorphism -1607 1G/2G for the gene MMP-1 de-
tected with restristed enzymes Xmnl and Alul is an 
risck factor for developing chronic periapical lesion. 
Individuals who are carriers of 2G/2G genotype and 
individuals with 1G/2G genotype (2G carriers) in this 
polymorphism shows affection for developing chronic 
periapical lesion. 
Polymorphism -519 A/G for the gene MMP-1 detected 
with restristed enzymes Kpnl is a risck for developing 
chronic periapical lesion and individuals who are car-
riers of G/G genotype and individuals with A/G geno-
type (G carriers) in this polymorphism shows affection 
for developing chronic periapical lesion. 
4. Conclusions
- With this study we can identify the genetic factors 
that are of enormously meaning for establishing the 
risk profile of the patients who have affection for devel-
oping chronic periapical lesions in Macedonian popu-
lation, and variations in gene alleles of the MMP-1 are 
markers for monitoring the risk and progression of this 
inflammatory process. 
- Our findings are fundamental for identification of 
gene polymorphism of MMP-1 in Macedonian popu-
lation, as a starting point in further investigations of 
MMPs gene expression, enable to predict the course 
and development of clinical sign of inflammatory 
process, indirectly pointed the adequate therapeutic 
method. 
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